FendX's Nanotechnology is Featured at Canadian Chemical Engineering Conference in Calgary, AB
- None.
- None.
Oakville, Ontario--(Newsfile Corp. - October 30, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings, announces that its nanotechnology is being featured at a prominent scientific Canadian Chemical Engineering conference ("CSChE") on October 30, 2023 to November 1, 2023 held in Calgary, Alberta.
On October 31, 2023, Professor Tohid Didar, Lead Researcher of FendX's nanotechnology development projects at McMaster University, will give an invited talk entitled "Micro and Nano Engineered Bio-interfaces for Diagnostics and Preventing Spread of Infectious Diseases" where the Company's REPELWRAP™ film and spray nanotechnology will be presented.
Furthermore, on October 31, 2023, Dr. Rod MacLachlan, a post-doctoral fellow at McMaster who is working on FendX's development projects, will speak on "Superhydrophobic and Oleophobic Materials Repel and Kill Pathogens" and provide details on a version of the Company's REPELWRAP™ film that integrates photoactive nanoparticles that demonstrates significant reduction in adhesion of pathogens through both repelling and killing properties. A publication of the detailed results of this work will be published in the coming weeks.
"We are very fortunate to be collaborating with such talented McMaster researchers who are working with us to advance our innovative and novel nanotechnology with the focus of creating films and sprays to protect high touch surfaces from contamination," said Dr. Carolyn Myers, President and CEO of FendX.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
Alyssa Barry, Investor Relations
1-833-947-5227
investor@fendxtech.com
For more information, please visit https://fendxtech.com/ and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; products under development; statements regarding the advancement of the Company's nanotechnology by researchers at McMaster University; products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company's such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/185664
FAQ
What is the name of the company featured in the press release?
What nanotechnology is being showcased at the conference?
What is the topic of Professor Tohid Didar's invited talk?
What will be discussed by Dr. Rod MacLachlan?
Will the detailed results of this work be published?
